SHOULD PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BE RECOMMENDED FOR TREATMENT OF INFRAGENICULATE POPLITEAL ARTERY OR TIBIOPERONEAL TRUNK STENOSIS

Citation
Gs. Treiman et al., SHOULD PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BE RECOMMENDED FOR TREATMENT OF INFRAGENICULATE POPLITEAL ARTERY OR TIBIOPERONEAL TRUNK STENOSIS, Journal of vascular surgery, 22(4), 1995, pp. 457-465
Citations number
27
Categorie Soggetti
Surgery,"Cardiac & Cardiovascular System","Peripheal Vascular Diseas
Journal title
ISSN journal
07415214
Volume
22
Issue
4
Year of publication
1995
Pages
457 - 465
Database
ISI
SICI code
0741-5214(1995)22:4<457:SPTABR>2.0.ZU;2-2
Abstract
Purpose: The purpose of this study was to determine the effectiveness of percutaneous transluminal angioplasty (PTA) for treatment of patien ts with localized stenosis of the infrageniculate popliteal artery and tibio-peroneal trunk (IGPA). Methods: The records of 25 patients unde rgoing IGPA PTA from 1983 to 1993 were reviewed. Patients underwent fo llow-up with clinical examinations, ankle-brachial indexes, Duplex sca nning, and arteriography. Demographic variables and cardiovascular ris k factors were analyzed and correlated with outcome. Results: Mean fol low-up was 44 months. With life-table analysis, clinical and hemodynam ic success was 59%, 32%, and 20% at 1, 2, and 3 years, respectively. A verage time to recurrence was 17 months. Sixteen patients required a s ubsequent procedure; two had only repeat PTA, six had repeat PTA follo wed by arterial bypass, and eight had bypass alone. The mean additiona l benefit of repeat PTA was 8 months. Eleven of the 14 patients treate d with bypass became symptom-free with patent grafts at a mean follow- up of 52 months. No risk factor was statistically significant in predi cting success of IGPA PTA. Conclusions: IGPA PTA is an expensive tempo rizing measure with a high rate of recurrence requiring subsequent int ervention. The procedure should be restricted to patients with limited life expectancy or contraindications to operation.